Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer

Background: Xihuang Wan (XHW), a purgative and detoxifying agent, is commonly utilized in modern medicine as a treatment and adjuvant therapy for various malignancies, including breast cancer, liver cancer, and lung cancer. A clinical study demonstrated the potential usefulness of the combination of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yuting, Guo, Yanlei, Luo, Hua, Wang, Menglei, Chen, Fang, Cui, Huawei, Chen, Ping, Yin, Zhujun, Li, Li, Dai, Ying, Zeng, Jin, Zhao, Junning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110895/
https://www.ncbi.nlm.nih.gov/pubmed/37081969
http://dx.doi.org/10.3389/fphar.2023.1164827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110895/
https://www.ncbi.nlm.nih.gov/pubmed/37081969
http://dx.doi.org/10.3389/fphar.2023.1164827

Ejemplares similares